Kibwana, Upendo O.
Maganda, Betty A.
Mikomangwa, Wigilya P.
Mutagonda, Ritah
Myemba, David T.
Nkinda, Lilian
Mwakawanga, Dorkasi L.
Ndayishimiye, Pacifique
Njiro, Belinda J.
Ndumwa, Harrieth P.
Marealle, Alphonce I.
Mlyuka, Hamu J.
Felix, Fatuma F.
Kilonzi, Manase
Sambayi, Godfrey
Makuka, Gerald J.
Kubigwa, Samson W.
Kunambi, Peter P.
Sirili, Nathanael
Mfaume, Rashid
Nshau, Arapha Bashir
Bwire, George M.
Nyankesha, Elevanie
Scherpbier, Robert
Funding for this research was provided by:
Welcome Trust (216341/Z/19/Z)
Article History
Received: 25 November 2023
Accepted: 11 October 2024
First Online: 24 October 2024
Declarations
:
: Ethical approval to conduct this study was obtained from the Muhimbili University of Health and Allied Sciences Ethical Review Board (Reference number: MUHAS-REC-3–2020-109). Permission to conduct the study at the regions was requested from the Regional Medical Officer In charge and Regional Pharmacist. Written informed consents after explaining the purpose of the study were requested from focused group participants. To ensure the study site and participants’ confidentiality, we presented the results using a professional category and number to represent a region. All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests